4.04
price down icon5.39%   -0.23
after-market Dopo l'orario di chiusura: 4.05 0.010 +0.25%
loading
Precedente Chiudi:
$4.27
Aprire:
$4.26
Volume 24 ore:
53,942
Relative Volume:
0.54
Capitalizzazione di mercato:
$229.35M
Reddito:
-
Utile/perdita netta:
$-66.86M
Rapporto P/E:
-3.3667
EPS:
-1.2
Flusso di cassa netto:
$-58.82M
1 W Prestazione:
+0.50%
1M Prestazione:
+1.76%
6M Prestazione:
-18.71%
1 anno Prestazione:
-15.48%
Intervallo 1D:
Value
$4.04
$4.325
Intervallo di 1 settimana:
Value
$3.945
$4.325
Portata 52W:
Value
$2.60
$7.77

Design Therapeutics Inc Stock (DSGN) Company Profile

Name
Nome
Design Therapeutics Inc
Name
Telefono
858-293-4900
Name
Indirizzo
6005 HIDDEN VALLEY ROAD, CARLSBAD
Name
Dipendente
56
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-10
Name
Ultimi documenti SEC
Name
DSGN's Discussions on Twitter

Confronta DSGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
DSGN
Design Therapeutics Inc
4.04 241.27M 0 -66.86M -58.82M -1.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Design Therapeutics Inc Stock (DSGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-07 Aggiornamento Piper Sandler Neutral → Overweight
2023-11-14 Downgrade Piper Sandler Overweight → Neutral
2023-08-15 Downgrade RBC Capital Mkts Outperform → Sector Perform
2023-08-15 Downgrade SVB Securities Outperform → Market Perform
2023-08-15 Downgrade Wedbush Outperform → Neutral
2023-05-04 Aggiornamento Goldman Sell → Neutral
2022-06-10 Iniziato Wedbush Outperform
2022-05-02 Iniziato RBC Capital Mkts Outperform
2022-01-19 Iniziato Goldman Sell
2021-04-20 Iniziato Goldman Neutral
2021-04-20 Iniziato Piper Sandler Overweight
2021-04-20 Iniziato SVB Leerink Outperform
Mostra tutto

Design Therapeutics Inc Borsa (DSGN) Ultime notizie

pulisher
Jul 24, 2025

How high can Design Therapeutics Inc. stock price go in 2025Breakthrough stock performance - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Design Therapeutics Inc. stock pricePhenomenal returns - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

Design Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Real-Time Monitoring - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Design Therapeutics Inc. stockPhenomenal capital gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Design Therapeutics Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Is ECASH(ethereumcash) a Good InvestmentLow Volatility High Yield Stocks - Newser

Jul 21, 2025
pulisher
Jul 20, 2025

What drives AORT stock priceExceptional market positioning - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Is Laureate Education Inc. a good long term investmentPhenomenal capital gains - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Best Indian Stocks for Portfolio Protection AI Recommended Market StrategiesPhenomenal wealth increase - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What analysts say about SBXC WS stockOutstanding capital appreciation - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is Design Therapeutics Inc. stock a growth or value playFree Membership Group - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

Design Therapeutics (NASDAQ:DSGN) Stock Price Down 3.1% – Should You Sell? - Defense World

Jul 18, 2025
pulisher
Jul 16, 2025

Why Design Therapeutics Inc. stock attracts strong analyst attentionDefensive Stock Picks with Upside - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

Why Synaptogenix Inc. stock attracts strong analyst attentionSecure Your Capital Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Design Therapeutics Inc. stock price move sharplyDaily Breakout Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How SIMAU stock performs during market volatilityFast Moving Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Sionna Therapeutics Inc. stock attracts strong analyst attentionFree VIP Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Design Therapeutics Inc. stock performs during market volatilityElite Stock Shortlist - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

High-Potential Biotech Penny Stocks in 2025: ProKidney and Design Therapeutics Lead the Way - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

Penny Stocks To Watch In July 2025 - simplywall.st

Jul 10, 2025
pulisher
Jul 10, 2025

Maze Therapeutics Soars 11.68% on Wedbush's Outperform Rating - AInvest

Jul 10, 2025
pulisher
Jun 26, 2025

BioVie Highlights Patient-Centric Design of SUNRISE-PD - GlobeNewswire

Jun 26, 2025
pulisher
Jun 17, 2025

FDA Boosts CERo's Revolutionary T Cell Therapy with Orphan Drug Status for Deadly Blood Cancer - Stock Titan

Jun 17, 2025
pulisher
Jun 14, 2025

PRDS(brise paradise) Future OutlookFree Group Entry - Newser

Jun 14, 2025
pulisher
Jun 12, 2025

Design Therapeutics Confirms Directors at Annual Meeting - TipRanks

Jun 12, 2025

Design Therapeutics Inc Azioni (DSGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):